Home
Home » companies

Vivus

VIVUS Earnings: Here’s Why Investors are Not Excited Now

VIVUS Earnings: Here’s Why Investors are Not Excited Now
Wall St. Cheat Sheet

This Week in Biotech

This Week in Biotech
Motley Fool

Vivus, Inc.: Second Rejection And Upcoming Earnings, Patience Required For Investors

Vivus, Inc.: Second Rejection And Upcoming Earnings, Patience Required For Investors
Seeking Alpha

CHMP rejects Vivus diet pill again

CHMP rejects Vivus diet pill again
Pharma Times, UK

This Obesity Bet Just Became More Attractive

This Obesity Bet Just Became More Attractive
Motley Fool

Slow and steady can win the diet drug race: Vivus' launch of Belviq

Slow and steady can win the diet drug race: Vivus' launch of Belviq
Reuters

EnteroMedics: Fat Zapper or Pulsing Placebo?

EnteroMedics: Fat Zapper or Pulsing Placebo?
TheStreet.com

Vivus up on heart drug study

Vivus up on heart drug study
Investors Business Daily

Vivus Stock Up On Qsymia Heart Disease Study

Vivus Stock Up On Qsymia Heart Disease Study
Investors.com

The Obesity Epidemic: EnteroMedics' New Treatment Approach

The Obesity Epidemic: EnteroMedics' New Treatment Approach
Seeking Alpha